Triple Lock on Carbs & Fats – Figurbalan® Chestnut Extract for Rebound-Free Weight Freedom

In the 16th century, Li Shizhen’s Compendium of Materia Medica recorded that chestnuts “nourish the stomach and kidneys, and sustain satiety.” Centuries later, modern analytical science is validating what traditional knowledge long suggested: the polyphenols found in chestnuts engage multiple metabolic pathways simultaneously, offering a breadth of mechanistic support rarely found in botanical weight management ingredients.

Part 1: Triple-Target Enzyme Inhibition — Addressing Energy Intake at Its Source

Weight management, at its biochemical core, is a function of energy balance. On the intake side, carbohydrates and fats represent the two primary caloric sources — and both depend on specific hydrolytic enzymes for digestion and absorption. What distinguishes Figurbalan® chestnut extract from single-target ingredients such as standard white kidney bean extract is its ability to engage three digestive pathways in parallel.

The first target is α-amylase. As the initial gatekeeper of starch digestion, α-amylase breaks down long-chain starches from staple foods into maltose and oligosaccharides. The oligomeric proanthocyanidins (OPCs) in chestnut extract work through a dual mechanism: they form direct complexes with starch, reducing its digestibility, while simultaneously inhibiting α-amylase activity — limiting the pool of carbohydrate substrates available for further breakdown.

The second target is α-glucosidase. This is the rate-limiting enzyme for carbohydrate absorption — it hydrolyzes disaccharides such as maltose and sucrose into absorbable glucose. Figurbalan® demonstrates particularly strong inhibition of this enzyme, attributable to its catechin and ellagic acid content. Undigested carbohydrates that reach the large intestine undergo fermentation by gut microbiota, producing short-chain fatty acids (SCFAs). These SCFAs activate G protein-coupled receptors, stimulating L-cells to secrete GLP-1 and PYY — endogenous satiety hormones that are central to the body’s natural appetite regulation system.

The third target is pancreatic lipase. Fat digestion relies on pancreatic lipase to break down triglycerides into absorbable free fatty acids. The gallic acid and other polyphenols in Figurbalan® demonstrate measurable inhibitory activity against pancreatic lipase, extending the ingredient’s mechanism from carbohydrate management to include dietary fat — a true dual-macronutrient approach.

Part 2: Multi-Dimensional Evidence — From Bench to In Vivo

In the ingredients industry, elegant mechanisms require rigorous data. Below is the evidence chain supporting Figurbalan® chestnut extract, spanning in vitro enzyme assays through in vivo models.

A. In Vitro Enzyme Inhibition Data

In standardized enzyme activity assays, Figurbalan® chestnut extract demonstrated robust inhibitory capacity: IC₅₀ of 14.5 μg/mL against yeast-derived α-glucosidase, 39.5 μg/mL against porcine pancreatic α-amylase, 290 μg/mL against porcine pancreatic lipase, and 74.0 μg/mL against bovine pancreatic lipase [1][2].

These figures become more compelling when benchmarked against common alternatives. Under identical conditions, a commercial white kidney bean extract (1,100 U/mg) showed an IC₅₀ of 350 μg/mL against α-amylase — nearly 9 times higher than Figurbalan®, meaning roughly an order of magnitude more material was required to achieve comparable inhibition. A second white kidney bean sample (3,000 U/g) showed no measurable α-amylase inhibition at all. Mulberry leaf extract (5% DNJ) yielded an IC₅₀ of 30 μg/mL against α-glucosidase — more than double that of Figurbalan®. Sugarcane polyphenols (polyphenol content ≥20%) recorded an IC₅₀ of 210 μg/mL, a 14-fold difference [1].

B. In Vivo: Postprandial Glucose Response

In a starch-loading study with healthy mice, the group receiving 2 g/kg starch plus 0.3 g/kg Figurbalan® chestnut extract showed a 28.80% lower postprandial blood glucose peak compared to the starch-only control group — and outperformed the 1 g/kg white kidney bean extract group [1]. These results indicate that Figurbalan® supports a healthier postprandial glucose response at substantially lower doses than benchmark ingredients, an important consideration for formulation economics and capsule-fill efficiency.

C. In Vivo: Long-Term Body Weight Management

In a 12-week study using C57BL/6J mice on a high-fat diet (60% of calories from fat), the group receiving 0.3 g/kg Figurbalan® chestnut extract showed significantly lower body weight than the model control group beginning at week 7 (P<0.05), with differences reaching high statistical significance at weeks 10–12 (P<0.01), trending similarly to the positive control group [3][4].

D. Metabolic Pathway Validation — Beyond Inhibition, Toward Regulation

Figurbalan®’s deeper value proposition lies not only in modulating digestive enzyme activity, but in influencing how the body processes energy at the metabolic level. Two independent animal studies have characterized the underlying molecular mechanisms:

AMPK/ACC Pathway Activation. Research published in a peer-reviewed journal demonstrated that chestnut shell polyphenols significantly upregulated hepatic protein expression of p-AMPK/AMPK, p-ACC/ACC, and PPARα in high-fat diet mice, while downregulating SREBP-1c and HMGCR expression [4]. In practical terms, this signaling cascade effectively promotes fatty acid β-oxidation while suppressing de novo lipogenesis — supporting the body’s natural fat-metabolizing pathways.

LEPR-JAK2/STAT3 Pathway Activation. A 2023 study confirmed that chestnut shell polyphenols activate the leptin receptor-JAK2-STAT3 signal transduction pathway, ameliorating high-fat diet-induced leptin resistance [3]. Leptin resistance is a well-characterized factor in metabolic dysregulation — when the brain becomes desensitized to leptin signaling, the body may persistently register a “hunger” state, undermining appetite control. Figurbalan® appears to help restore sensitivity within this feedback loop, based on preclinical findings.

E. Gut Microbiota Modulation — Supporting Long-Term Metabolic Health

A 2025 study further demonstrated that bound polyphenols from chestnut inner skin significantly increased gut microbial richness in SD rats, elevated the relative abundance of beneficial genera such as Lactobacillus, reduced the proportion of potentially harmful genera such as Clostridium, and increased the Bacteroidetes-to-Firmicutes ratio — a metric widely associated with a leaner metabolic profile [5]. These findings suggest that Figurbalan® supports metabolic health not through a simple “block-and-excrete” mechanism, but by fostering a gut microbial environment conducive to long-term metabolic balance.

Part 3: Formulation Applications & World-Way Quality Assurance

Based on the body of evidence outlined above, Figurbalan® chestnut extract offers substantial formulation flexibility for weight management products:

Dosage Forms. Gummies, tablets, and hard capsules are all established delivery formats, with market validation across South Korea, Japan, Taiwan, and the United States. Powder formats are also well-suited for stick packs, ready-to-mix beverages, and meal replacement shakes.

Combination Strategies. Pairing Figurbalan® with white kidney bean extract creates complementary α-amylase and α-glucosidase targeting. Combining with prebiotics or probiotics amplifies the gut microbiome dimension. Formulating alongside green coffee extract (chlorogenic acid) may provide additive AMPK pathway support.

Recommended Use Level. 100–300 mg per day, taken 15 minutes before or with meals.

Of course, formulation concepts are only as good as the ingredient that delivers them. World-Way has built a complete quality assurance system for Figurbalan®, spanning from raw material sourcing to finished powder:

Origin-Controlled Sourcing. Raw chestnuts are procured from designated growing regions. Every incoming lot is screened using HPLC, GC-MS, and ICP-MS to verify identity, potency, and purity.

Ultrasound-Assisted Moderate-Temperature Extraction. Unlike conventional high-temperature decoction (above 120°C), World-Way’s ultrasound-assisted extraction operates at 40–50°C, preserving heat-sensitive actives such as OPCs and catechins while reducing extraction time and improving yield efficiency.

Vacuum Concentration & Spray Drying. Low-temperature concentration under vacuum prevents oxidation and degradation of thermolabile polyphenols. Spray drying produces a free-flowing powder with uniform particle size distribution, excellent solubility, and superior blendability.

Three-Dimensional Mixing. This step ensures batch-to-batch consistency in polyphenol content, keeping inter-lot variation within a narrow specification band.

These technical controls translate into a verifiable specification: Figurbalan® chestnut extract delivers polyphenol content ≥25% and α-glucosidase IC₅₀ ≤25 μg/mL — not as marketing claims, but as traceable data points on every certificate of analysis.

Conclusion

The weight management ingredient market is never short on new offerings. What is rare is an ingredient that can withstand scrutiny across four independent layers of evidence: enzyme assays, animal models, metabolic pathway analysis, and competitive benchmarking. Figurbalan® chestnut extract brings this rigor — with triple-target enzyme inhibition (α-amylase, α-glucosidase, pancreatic lipase) as its primary mechanism, AMPK and LEPR-JAK2/STAT3 dual-pathway activation as its metabolic foundation, and gut microbiota remodeling as its long-term maintenance strategy.

If you are developing a next-generation weight management product and seek a differentiated ingredient backed by data, mechanism, and certification, we invite you to explore Figurbalan®. Visit www.world-way.net or contact our technical team to request the complete Figurbalan® technical dossier and samples.

Let the science speak for your product.

References

[1] Zhang YY, et al. Chestnut inner skin extract inhibits α-amylase and α-glucosidase activities and modulates starch digestibility. Food Chemistry. 2020.

[2] Huang XW, et al. Inhibition of pancreatic lipase by chestnut extract. Food Science. 2021.

[3] Liu SW, et al. Chinese chestnut shell polyphenol extract regulates the JAK2/STAT3 pathway to alleviate high-fat diet-induced, leptin-resistant obesity in mice. Food & Function. 2023.

[4] Zhang XY, et al. Chestnut shell polyphenols ameliorate lipid metabolism disorders in obese mice via the AMPK signaling pathway. Food Science. 2023.

[5] Xie CY, et al. Effects of chestnut bound polyphenols on gut microbiota in SD rats. Food and Fermentation Industries. 2025.